Romain Micol

Title: Romain Micol: Innovator in Mycobacterial Antigen Vaccines

Introduction

Romain Micol is a notable inventor based in Lyons, France. He has made significant contributions to the field of immunology, particularly in the development of vaccines targeting mycobacterial infections. His innovative work has the potential to enhance the effectiveness of immunogenic treatments.

Latest Patents

Romain Micol holds a patent for a mycobacterial antigen vaccine. This invention relates to immunogenic combinations that comprise at least five antigens of a species, as well as their fusion and nucleic acid molecules encoding such combined antigens. The patent also covers vectors, host cells, and compositions that include these combinations of mycobacterial antigens and fusion polypeptides. Furthermore, it outlines methods for recombinantly producing these components and their applications in inducing or stimulating an immune response against infections or diseases associated with such infections. The invention also includes antibodies directed to these mycobacterial antigens, which can be utilized in diagnostic methods and detection kits.

Career Highlights

Romain Micol is associated with Transgene S.A., a company that focuses on developing innovative immunotherapies for cancer and infectious diseases. His work at Transgene has allowed him to contribute to groundbreaking research in the field of vaccine development.

Collaborations

Romain has collaborated with notable colleagues such as Emmanuel Tupin and Charles Antoine Coupet. These collaborations have further enriched his research and development efforts in the field of immunology.

Conclusion

Romain Micol's contributions to the field of mycobacterial antigen vaccines highlight his innovative spirit and dedication to advancing medical science. His work has the potential to significantly impact the treatment of infections and improve public health outcomes.